ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag european commission developmental biology microbiology

European Research Council gets thumbs up
Laura Spinney(LFSpinney@compuserve.com) | Feb 19, 2003 | 2 min read
Scientists broadly support idea of new pan-European research body.
An illustration of green bacteria floating above neutral-colored intestinal villi
The Inside Guide: The Gut Microbiome’s Role in Host Evolution
Catherine Offord | Jul 1, 2021 | 10+ min read
Bacteria that live in the digestive tracts of animals may influence the adaptive trajectories of their hosts.
Top Ten Innovations 2011
The Scientist | Jan 1, 2012 | 10+ min read
Our list of the best and brightest products that 2011 had to offer the life scientist
Frontlines
Paula Park | Jul 7, 2002 | 6 min read
Frontlines Image: Erica P. Johnson Stop brain drain now Six of Europe's Nobel laureates chastised the European Union's policies on research funding with a letter to all 12 EU leaders demanding action. The six--three winners of the medicine prize in the 1970s and 1980s, two physicists, and a chemist--want funds doubled to stem the flow of talented young scientists from Europe to the United States. "Brain drain--young talented scientists leaving their countries--is making itself felt in most
Frontlines
Michaela Torkar | Jul 7, 2002 | 6 min read
Six of Europe's Nobel laureates chastised the European Union's policies on research funding with a letter to all 12 EU leaders demanding action. The six--three winners of the medicine prize in the 1970s and 1980s, two physicists, and a chemist--want funds doubled to stem the flow of talented young scientists from Europe to the United States. "Brain drain--young talented scientists leaving their countries--is making itself felt in most EU countries," the letter warns. The EU has pledged to raise
Updated July 9
Track COVID-19 Vaccines Advancing Through Clinical Trials
The Scientist | Apr 7, 2020 | 10+ min read
Find the latest updates in this one-stop resource, including efficacy data and side effects of approved shots, as well as progress on new candidates entering human studies.
How Orphan Drugs Became a Highly Profitable Industry
Diana Kwon | May 1, 2018 | 10+ min read
Government incentives, advances in technology, and an army of patient advocates have spun a successful market—but abuses of the system and exorbitant prices could cause a backlash.

Run a Search

ADVERTISEMENT